Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
February 26 2024 - 7:00AM
Apellis Pharmaceuticals, Inc., (Nasdaq: APLS) today announced
that the company will participate in the following March investor
conferences:
- TD Cowen 44th Annual Healthcare Conference:
- Fireside chat on Monday, March 4, 2024, at 2:10 p.m. ET
- Ophthalmology Corporate Panel Discussion on Tuesday, March 5,
2024, at 9:10 a.m. ET
- Raymond James & Associates’ 45th Annual Institutional
Investors Conference: Fireside chat on Tuesday, March 5, 2024, at
11:00 a.m. ET
The live conference webcasts will be posted on the “Events and
Presentations” page of the “Investors and Media” section of the
company’s website. A replay of the webcasts will be available for
approximately 90 days following the event.
About ApellisApellis Pharmaceuticals, Inc. is a
global biopharmaceutical company that combines courageous science
and compassion to develop life-changing therapies for some of the
most challenging diseases patients face. We ushered in the first
new class of complement medicine in 15 years and now have two
approved medicines targeting C3. These include the first-ever
therapy for geographic atrophy, a leading cause of blindness around
the world. We believe we have only begun to unlock the potential of
targeting C3 across serious retinal, rare, and neurological
diseases. For more information, please visit
http://apellis.com or follow us
on Twitter and LinkedIn.
Investor Contact: Meredith
Kaya meredith.kaya@apellis.com617.599.8178
Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
From Apr 2024 to May 2024
Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
From May 2023 to May 2024